These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7594663)

  • 61. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differing serologic responses to an haemophilus influenzae type b polysaccharide-neisseria meningitidis outer membrane protein conjugate (PRP-OMPC) vaccine in australian aboriginal and caucasian infants - implications for disease epidemiology.
    Guthridge S; McIntyre P; Isaacs D; Hanlon M; Patel M
    Vaccine; 2000 May; 18(23):2584-91. PubMed ID: 10775792
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Haemophilus influenzae type b vaccines: history, choice and comparisons.
    Decker MD; Edwards KM
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S113-6. PubMed ID: 9781742
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease.
    Molrine DC; George S; Tarbell N; Mauch P; Diller L; Neuberg D; Shamberger RC; Anderson EL; Phillips NR; Kinsella K; Ambrosino DM
    Ann Intern Med; 1995 Dec; 123(11):828-34. PubMed ID: 7486464
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
    Gray BM
    Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 micrograms liquid formulation: a comparison of three lots with the 15.0 micrograms lyophilized formulation. Study Group for 7.5 micrograms Liquid PedvaxHIB.
    Mendelman PM; Feeley L; Bird S; Staub T; Matthews H; Del Beccaro MA; Overturf G; Lee A; Ellis R; Staub J; Szymanski S; Donnelly J; Hennessey JP; Kniskern P
    Vaccine; 1997; 15(6-7):775-81. PubMed ID: 9178481
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical experience with PedvaxHIB, a conjugate vaccine of Haemophilus influenzae type b polysaccharide--Neisseria meningitidis outer membrane protein.
    Ahonkhai VI; Lukacs LJ; Jonas LC; Calandra GB
    Vaccine; 1991 Jun; 9 Suppl():S38-41; discussion S42-3. PubMed ID: 1891956
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine.
    Pérez-Melgosa M; Ochs HD; Linsley PS; Laman JD; van Meurs M; Flavell RA; Ernst RK; Miller SI; Wilson CB
    Eur J Immunol; 2001 Aug; 31(8):2373-81. PubMed ID: 11500820
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Laboratory correlates of protection against Haemophilus influenzae type b disease. Importance of assessment of antibody avidity and immunologic memory.
    Granoff DM; Lucas AH
    Ann N Y Acad Sci; 1995 May; 754():278-88. PubMed ID: 7625664
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines.
    Granoff DM; Holmes SJ
    Vaccine; 1991 Jun; 9 Suppl():S30-4; discussion S42-3. PubMed ID: 1891954
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Response to Haemophilus influenzae type B conjugate vaccine in children undergoing splenectomy.
    Ambrosino DM; Lee MY; Chen D; Shamberger RC
    J Pediatr Surg; 1992 Aug; 27(8):1045-7; discussion 1048. PubMed ID: 1403533
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.
    Rubinstein LJ; García-Ojeda PA; Michon F; Jennings HJ; Stein KE
    Infect Immun; 1998 Nov; 66(11):5450-6. PubMed ID: 9784556
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A high degree of natural immunologic priming to the capsular polysaccharide may not prevent Haemophilus influenzae type b meningitis.
    Anderson P; Ingram DL; Pichichero ME; Peter G
    Pediatr Infect Dis J; 2000 Jul; 19(7):589-91. PubMed ID: 10917213
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine.
    Granoff DM; McHugh YE; Raff HV; Mokatrin AS; Van Nest GA
    Infect Immun; 1997 May; 65(5):1710-5. PubMed ID: 9125551
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines.
    Kauppi M; Eskola J; Käyhty H
    Pediatr Infect Dis J; 1995 Apr; 14(4):286-94. PubMed ID: 7603810
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys.
    Devi SJ; Zollinger WD; Snoy PJ; Tai JY; Costantini P; Norelli F; Rappuoli R; Frasch CE
    Infect Immun; 1997 Mar; 65(3):1045-52. PubMed ID: 9038314
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anti-polyribosyl-ribitol phosphate and anti-N. meningitidis outer membrane protein antibody levels following PRP-OMP conjugate vaccination.
    Wong VK; Kim KS
    Vaccine; 1993; 11(9):979-80. PubMed ID: 8212847
    [No Abstract]   [Full Text] [Related]  

  • 79. Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenzae type b conjugate vaccine.
    Rutstein RM; Rudy BJ; Cnaan A
    Arch Pediatr Adolesc Med; 1996 Aug; 150(8):838-41. PubMed ID: 8704891
    [TBL] [Abstract][Full Text] [Related]  

  • 80. IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in young infants.
    Ambrosino DM; Sood SK; Lee MC; Chen D; Collard HR; Bolon DL; Johnson C; Daum RS
    Pediatr Infect Dis J; 1992 Oct; 11(10):855-9. PubMed ID: 1408486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.